Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Taylor L. Voss"'
Autor:
Heather L. Gray-Edwards, Anne S. Maguire, Nouha Salibi, Lauren E. Ellis, Taylor L. Voss, Elise B. Diffie, Jey Koehler, Ashley N. Randle, Amanda R. Taylor, Brandon L. Brunson, Thomas S. Denney, Ronald J. Beyers, Atoska S. Gentry, Amanda L. Gross, Ana R. Batista, Miguel Sena-Esteves, Douglas R. Martin
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 17, Iss , Pp 258-270 (2020)
GM1 gangliosidosis (GM1) is a fatal neurodegenerative lysosomal storage disease that occurs most commonly in young children, with no effective treatment available. Long-term follow-up of GM1 cats treated by bilateral thalamic and deep cerebellar nucl
Externí odkaz:
https://doaj.org/article/e5a002b5c4934f989fe4e2733f002031
Autor:
Heather L. Gray-Edwards, Xuntian Jiang, Ashley N. Randle, Amanda R. Taylor, Taylor L. Voss, Aime K. Johnson, Victoria J. McCurdy, Miguel Sena-Esteves, Daniel S. Ory, Douglas R. Martin
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 6, Iss C, Pp 135-142 (2017)
GM1 gangliosidosis is a fatal lysosomal disorder, for which there is no effective treatment. Adeno-associated virus (AAV) gene therapy in GM1 cats has resulted in a greater than 6-fold increase in lifespan, with many cats remaining alive at >5.7 year
Externí odkaz:
https://doaj.org/article/3e3a1ecbcf1a457a8a1a35bcff0c25d7
Autor:
Ronald J. Beyers, Ana Rita Batista, Heather L. Gray-Edwards, Miguel Sena-Esteves, Thomas S. Denney, Ashley N. Randle, Lauren E. Ellis, Jey W. Koehler, Nouha Salibi, Anne S Maguire, Taylor L. Voss, Amanda L. Gross, Elise B. Diffie, Amanda R. Taylor, Atoska S. Gentry, Douglas R. Martin, Brandon L. Brunson
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 17, Iss, Pp 258-270 (2020)
Molecular Therapy. Methods & Clinical Development
Molecular Therapy. Methods & Clinical Development
GM1 gangliosidosis (GM1) is a fatal neurodegenerative lysosomal storage disease that occurs most commonly in young children, with no effective treatment available. Long-term follow-up of GM1 cats treated by bilateral thalamic and deep cerebellar nucl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5d3f49a49de71f222643f752799d590
http://www.sciencedirect.com/science/article/pii/S2329050119301536
http://www.sciencedirect.com/science/article/pii/S2329050119301536
Autor:
Ashley N. Randle, Aime K. Johnson, Heather L. Gray-Edwards, Xuntian Jiang, Victoria J. McCurdy, Daniel S. Ory, Taylor L. Voss, Miguel Sena-Esteves, Amanda R. Taylor, Douglas R. Martin
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 6, Iss C, Pp 135-142 (2017)
Molecular Therapy. Methods & Clinical Development
Molecular Therapy. Methods & Clinical Development
GM1 gangliosidosis is a fatal lysosomal disorder, for which there is no effective treatment. Adeno-associated virus (AAV) gene therapy in GM1 cats has resulted in a greater than 6-fold increase in lifespan, with many cats remaining alive at >5.7 year
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a2d678e7247141f060d6e69d49ea9b5
https://doi.org/10.1016/j.omtm.2017.07.005
https://doi.org/10.1016/j.omtm.2017.07.005